Species and age determination of central nervous system tissue by fatty acid patterns von Grießbach, Maria, Hartmann, Franziska, Massag, Nicole, Baumann, Daniela, Krex, Christian, Biedermann, Wolfgang, Truyen, Uwe, Lücker, Ernst

Volltext

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient grou... von Weller, Michael, Weber, Ruthild G., Willscher, Edith, Riehmer, Vera, Hentschel, Bettina, Kreuz, Markus, Felsberg, Jörg, Beyer, Ulrike, Löffler-Wirth, Henry, Kaulich, Kerstin, Steinbach, Joachim P., Hartmann, Christian, Gramatzki, Dorothee, Schramm, Johannes, Westphal, Manfred, Schackert, Gabriele, Simon, Matthias, Martens, Tobias, Boström, Jan, Hagel, Christian, Sabel, Michael, Krex, Dietmar, Tonn, Jörg C., Wick, Wolfgang, Noell, Susan, Schlegel, Uwe, Radlwimmer, Bernhard, Pietsch, Torsten, Loeffler, Markus, von Deimling, Andreas, Binder, Hans, Reifenberger, Guido

Volltext

Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network von WELLER, Michael, FELSBERG, Jörg, HEESE, Oliver, KREX, Dietmar, NIKKHAH, Guido, PIETSCH, Torsten, WIESTLER, Otmar, REIFENBERGER, Guido, VON DEIMLING, Andreas, LOEFFLER, Markus, HARTMANN, Christian, BERGER, Hilmar, STEINBACH, Joachim P, SCHRAMM, Johannes, WESTPHAL, Manfred, SCHACKERT, Gabriele, SIMON, Matthias, TONN, Jörg C

Volltext

Long-term survival with glioblastoma multiforme von Krex, Dietmar, Klink, Barbara, Hartmann, Christian, von Deimling, Andreas, Pietsch, Torsten, Simon, Matthias, Sabel, Michael, Steinbach, Joachim P., Heese, Oliver, Reifenberger, Guido, Weller, Michael, Schackert, Gabriele

Volltext

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a random... von Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter, Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh, Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert, Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes, Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C, Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang, Weller, Michael, Fimmers, Rolf, Schmid, Matthias, Hattingen, Elke, Pietsch, Torsten, Coch, Christoph, Glas, Martin

Volltext

Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma von Scholz, Alexander, Harter, Patrick N, Cremer, Sebastian, Yalcin, Burak H, Gurnik, Stefanie, Yamaji, Maiko, Di Tacchio, Mariangela, Sommer, Kathleen, Baumgarten, Peter, Bähr, Oliver, Steinbach, Joachim P, Trojan, Jörg, Glas, Martin, Herrlinger, Ulrich, Krex, Dietmar, Meinhardt, Matthias, Weyerbrock, Astrid, Timmer, Marco, Goldbrunner, Roland, Deckert, Martina, Braun, Christian, Schittenhelm, Jens, Frueh, Jochen T, Ullrich, Evelyn, Mittelbronn, Michel, Plate, Karl H, Reiss, Yvonne

Volltext

Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas von Juratli, Tareq A, Thiede, Christian, Koerner, Mara V A, Tummala, Shilpa S, Daubner, Dirk, Shankar, Ganesh M, Williams, Erik A, Martinez-Lage, Maria, Soucek, Silke, Robel, Katja, Penson, Tristan, Krause, Mechthild, Appold, Steffen, Meinhardt, Matthias, Pinzer, Thomas, Miller, Julie J, Krex, Dietmar, Ely, Heather A, Silverman, Ian M, Christiansen, Jason, Schackert, Gabriele, Wakimoto, Hiroaki, Kirsch, Matthias, Brastianos, Priscilla K, Cahill, Daniel P

Volltext

Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma von Stasik, Sebastian, Juratli, Tareq A., Petzold, Andreas, Richter, Sven, Zolal, Amir, Schackert, Gabriele, Dahl, Andreas, Krex, Dietmar, Thiede, Christian

Volltext

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial von Wick, Wolfgang, Prof, Platten, Michael, Prof, Meisner, Christoph, PhD, Felsberg, Jörg, MD, Tabatabai, Ghazaleh, MD, Simon, Matthias, MD, Nikkhah, Guido, Prof, Papsdorf, Kirsten, MD, Steinbach, Joachim P, Prof, Sabel, Michael, MD, Combs, Stephanie E, MD, Vesper, Jan, MD, Braun, Christian, MD, Meixensberger, Jürgen, Prof, Ketter, Ralf, MD, Mayer-Steinacker, Regine, MD, Reifenberger, Guido, Prof, Weller, Michael, Prof

Volltext

TERT promoter mutation detection in cell-free tumor-derived DNA in patients with IDH wild-type glioblastomas - a pilot prospective study von Juratli, Tareq A, Stasik, Sebastian, Zolal, Amir, Schuster, Caroline, Richter, Sven, Daubner, Dirk, Juratli, Mazen A, Thowe, Rachel T, Hennig, Silke, Makina, Meriem, Meinhardt, Matthias, Lautenschlaeger, Tim, Schackert, Gabriele, Krex, Dietmar, Thiede, Christian

Volltext

Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups von Juratli, Tareq A., Tummala, Shilpa S., Riedl, Angelika, Daubner, Dirk, Hennig, Silke, Penson, Tristan, Zolal, Amir, Thiede, Christian, Schackert, Gabriele, Krex, Dietmar, Miller, Julie J., Cahill, Daniel P.

Volltext

Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection von Ringel, Florian, Pape, Haiko, Sabel, Michael, Krex, Dietmar, Bock, Hans Christoph, Misch, Martin, Weyerbrock, Astrid, Westermaier, Thomas, Senft, Christian, Schucht, Philippe, Meyer, Bernhard, Simon, Matthias

Volltext

Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN) von Brioli, Annamaria, Manz, Kirsi, Pfirrmann, Markus, Hänel, Mathias, Schwarzer, Andreas Christoph, Prange-Krex, Gabriele, Fabisch, Christian, Knop, Stefan, Illmer, Thomas, Krammer-Steiner, Beate, Hochhaus, Andreas, von Lilienfeld-Toal, Marie, Mügge, Lars-Olof

Volltext

Combined 1p/19q Loss in Oligodendroglial Tumors: Predictive or Prognostic Biomarker? von WELLER, Michael, BERGER, Hilmar, LOEFFLER, Markus, PIETSCH, Torsten, VON DEIMLING, Andreas, HARTMANN, Christian, SCHRAMM, Johannes, WESTPHAL, Manfred, SIMON, Matthias, GOLDBRUNNER, Roland, KREX, Dietmar, STEINBACH, Joachim P, OSTERTAG, Christoph B

Volltext

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial von Barrington, Sally F, Belada, David, Meignan, Michel, Ptáčník, Václav, Fingerle-Rowson, Günter R, Hiddemann, Wolfgang, Marcus, Robert E, Grigg, Andrew, Quach, Hang, Marlton, Paula, Offner, Fritz, Van eygen, Koen, Roitman, Daryl, Trneny, Marek, Le Du, Katell, Solal-Celigny, Philippe, Cartron, Guillaume, Foussard, Charles, Schmidt, Peter, Sökler, Martin, Schimmelpfennig, Christoph, Tonndorf, Solveig, Hänel, Mathias, Hess, Georg, Schalk, Enrico, Pfreundschuh, Michael, Herold, Michael, Forstpointner, Roswitha, Vehling-Kaiser, Ursula, Majolino, Ignazio, Balzarotti, Monica, Soler Campos, Alfonso, Marquez Navarro, Jose Antonio, Grande Garcia, Carlos, Nilsson-Ehle, Herman, Radford, John, Kruger, Anton, Culligan, Dominic, Dyer, Martin, Pettengell, Ruth, Al-Ismail, Saad, Al-Refaie, Faris, Blesing, Norbert, Macnamara, Christopher, O'callaghan, Ann, Haynes, Andrew, Bowles, Kristian, Gallop-Evans, Eve, Bailey, James, De Oliveira, Moacyr, Tezcan, Haluk, Kim, Kevin, Hatake, Kiyohiko, Ogura, Michinori, Uchida, Toshiki, Kinoshita, Tomohiro, Kirsch, Andreas, Koenigsmann, Michael, Dürig, Jan, Kneba, Michael, Bergmann, Lothar, Marks, Reinhard, Wulf, Gerald, Schmits, Rudolf, Lengfelder, Eva, Scott, Fiona, Taniwaki, Masafumi, Yoshida, Isao, Uike, Naokuni, Kamitsuji, Yuri, Iida, Shinsuke, Ohmine, Ken, Nosaka, Kisato, Ide, Kazuhiko, Ishikawa, Takayuki, Li, Wei, Yu, Li, Shi, Yuan Kai, Hong, Xiaonan, Feng, Jifeng, Zhan, Rong, Lin, Tongyu, Costello, Regis, Tournilhac, Olivier, Kirchen, Heinz, Hebart, Holger, Gurion, Ronit, Shpilberg, Ofer, Leoni, Pietro, Samoylova, Olga, Usui, Noriko, Izutsu, Koji, Ichinohe, Tatsuo, Kubo, Kohmei, Ishida, Fumihiro, Dakhil, Shaker, Maruyama, Dai, Kobayashi, Tsutomu, Wada, Katsuya, Minami, Yosuke

Volltext

First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis von Pouyiourou, M., Meyer, A., Stroux, A., Viardot, A., La Rosée, P., Maschmeyer, G., Kämpfe, D., Kahl, C., Vucinic, V., Monecke, A., Hirt, C., Weber, T., Meissner, J., Witzens-Harig, M., Böttcher, S., Schmalenberg, H., Marks, R., Prange-Krex, G., Kroschinsky, F., Hauf, E., Keller, U., Koch, K., Klapper, W., Herold, M., Scholz, Christian W.

Volltext

Rituximab Maintenance Versus Observation After Immunochemotherapy (R‐CHOP, R‐MCP, and R‐FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studie... von Hirt, Carsten, Hoster, Eva, Unterhalt, Michael, Hänel, Mathias, Prange‐Krex, Gabriele, Forstpointner, Roswitha, Florschütz, Axel, Graeven, Ullrich, Frickhofen, Norbert, Wulf, Gerald, Lengfelder, Eva, Lerchenmüller, Christian, Schlag, Rudolf, Dierlamm, Judith, Fischer von Weikersthal, Ludwig, Ahmed, Asima, Harich, Hanns‐Detlev, Rosenwald, Andreas, Klapper, Wolfram, Dreyling, Martin, Hiddemann, Wolfgang, Herold, Michael

Volltext

MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA‐09 trial von Tzaridis, Theophilos, Schäfer, Niklas, Weller, Johannes, Steinbach, Joachim‐Peter, Schlegel, Uwe, Seidel, Sabine, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Tonn, Jörg‐Christian, Grauer, Oliver, Kebir, Sied, Schneider, Matthias, Schaub, Christina, Vatter, Hartmut, Coch, Christoph, Glas, Martin, Fimmers, Rolf, Pietsch, Torsten, Reifenberger, Guido, Herrlinger, Ulrich, Felsberg, Jörg

Volltext

Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419) von Hertler, Caroline, Felsberg, Jörg, Gramatzki, Dorothee, Le Rhun, Emilie, Clarke, Jennifer, Soffietti, Riccardo, Wick, Wolfgang, Chinot, Olivier, Ducray, François, Roth, Patrick, McDonald, Kerrie, Hau, Peter, Hottinger, Andreas F., Reijneveld, Jaap, Schnell, Oliver, Marosi, Christine, Glantz, Michael, Darlix, Amélie, Lombardi, Giuseppe, Krex, Dietmar, Glas, Martin, Reardon, David A., van den Bent, Martin, Lefranc, Florence, Herrlinger, Ulrich, Razis, Evangelia, Carpentier, Antoine F., Phillips, Samuel, Rudà, Roberta, Wick, Antje, Tabouret, Emeline, Meyronet, David, Maurage, Claude-Alain, Rushing, Elisabeth, Rapkins, Robert, Bumes, Elisabeth, Hegi, Monika, Weyerbrock, Astrid, Aregawi, Dawit, Gonzalez-Gomez, Christian, Pellerino, Alessia, Klein, Martin, Preusser, Matthias, Bendszus, Martin, Golfinopoulos, Vassilis, von Deimling, Andreas, Gorlia, Thierry, Wen, Patrick Y., Reifenberger, Guido, Weller, Michael

Volltext

Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma12 von Stasik, Sebastian, Juratli, Tareq A., Petzold, Andreas, Richter, Sven, Zolal, Amir, Schackert, Gabriele, Dahl, Andreas, Krex, Dietmar, Thiede, Christian

Volltext